MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Transient myoclonic state in the elderly: A new entity in the classification of myoclonus

    T. Hashimoto, T. Doden, H. Sato (Matsumoto, Japan)

    Objective: To clarify the clinical picture of transient myoclonic state in elderly patients and to establish a position in the classification of myoclonus. Background: Transient…
  • 2016 International Congress

    Neurophysiological investigation of brainstem in idiopathic REM sleep behavior disorder (iRBD) through vestibular evoked myogenic potentials (VEMPs)

    E.R. de Natale, F. Ginatempo, I. Laccu, B. Mercante, A. Manca, M. Figorilli, M. Puligheddu, F. Deriu (Sassari, Italy)

    Objective: To investigate the degree of brainstem impairment in a cohort of patients with iRBD through recording of a VEMPs battery able to indirectly assess…
  • 2016 International Congress

    The temporal relationship between premonitory sensations and tics compared to obsessions

    V.C. Brandt, C. Beck, J. Hermanns, T. Bäumer, B. Zurowski, S. Anders, A. Münchau (Lübeck, Germany)

    Objective: Investigating the real-time relationship between premonitory urges and tics as compared to the urge to blink in healthy controls and the urge to execute…
  • 2016 International Congress

    Individualized botulinum toxin type A therapy of bilateral upper limb essential tremor by multi-sensor kinematic technology

    O. Samotus, H. Moradi, M. Jog (London, ON, Canada)

    Objective: To demonstrate efficacious and safe reduction in bilateral upper limb tremor severity by serial botulinum toxin type A injection parameters kinematically determined using a…
  • 2016 International Congress

    "Are patients with familial ET distinct from those with sporadic ET? Insight from 250 patients"

    M. Manjunath, A. Lenka, K. Jhunjhunwala, K.S. Bhalsing, P.K. Pal (Bengaluru, India)

    Objective: To explore if patients with familial ET(FET) are clinically and demographically distinct from those with sporadic ET(SET). Background: Essential tremor(ET) is the commonest tremor…
  • 2016 International Congress

    Timing control of gait in essential tremor patients vs. age-matched controls

    A.K. Rao, E.D. Louis, A.K. Rao (New York, NY, USA)

    Objective: (1) To examine if gait timing control is impaired in ET patients compared with age-matched controls. (2) To examine whether timing impairments are related…
  • 2016 International Congress

    Quantitative analysis of tremor in patients with cerebellar and brainstem lesions

    A. Kovács, Z. Farkas, A. Kamondi (Budapest, Hungary)

    Objective: The aim of our study was to investigate the characteristics of tremor in patients with cerebellar or brainstem lesions. Background: The cerebellum and the…
  • 2016 International Congress

    Core set of measures of balance for people with multiple sclerosis and cerebellar ataxia

    S.J. Winser, C.M. Smith, L.A. Hale, L.S. Claydon, S.L. Whitney, B. Klatt, J. Mottershead, I. Zaydan, R. Heyman, S. Winser (Dunedin, New Zealand)

    Objective: To examine the reliability, validity and interpretability of four measures in assessing the severity of balance dysfunction and short term treatment benefits on balance…
  • 2016 International Congress

    Fragile X-associated tremor/ataxia syndrome in two female patients

    L. Hvizdosova, M. Kaiserova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To report two cases of female patients with FXTAS. Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder with core features of action…
  • 2016 International Congress

    A unique phenotype associated with anti-GAD antibodies

    A.P. Mentreddi, S. Chitnis, P. Khemani (Dallas, TX, USA)

    Objective: To describe a case of hemiatiaxia, parkinsonism, and dystonia associated with anti-Glutamic Acid Decarboxylase (GAD) antibodies. Background: GAD antibodies have been implicated in endocrinopathies…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley